Skip to main content
. Author manuscript; available in PMC: 2019 Jul 17.
Published in final edited form as: Obstet Gynecol. 2017 Feb;129(2):355–362. doi: 10.1097/AOG.0000000000001838

Table 2.

Outcomes by Randomized Group

Outcome Variable Control (n=52) Intervention (n=51) P

Primary outcome
 Length of hospital stay (d) 52 [3.0 (2.0–3.0)] 51 [3.0 (2.0–3.0)] .36*
Secondary outcomes
 Day 0 narcotics 51 [10.0 (6.0–14.0)] 49 [5.5 (2.0–11.0)] .09*
 Day 1 narcotics 48 [12.6 (10.0–18.5)] 51 [10.0 (5.0–13.3)] .16*
 Day 2 narcotics 51 [10.0 (8.3–12.3)] 48 [7.5 (3.3–10.0)] .05*
 When ambulating .81
  Day 0 8 (16.0) 8 (16.3)
  Day 1 38 (76.0) 39 (79.6)
  Day 2 4 (8.0) 2 (4.1)
  Missing 2
 When flatus .08
  Day 1 5 (11.4) 0 (0.0)
  Day 2 9 (20.5) 16 (43.2)
  Day 3 16 (36.4) 12 (32.4)
  Day 4 or more (in hospital) 5 (11.4) 4 (10.8)
  None before discharge 9 (20.5) 5 (13.5)
  Missing 8 14
 Emesis .86§
  No 39 (75.0) 39 (76.5)
  Yes 13 (25.0) 12 (23.5)
 Physical therapy used <.001§
  No 32 (62.8) 11 (21.6)
  Yes 19 (37.3) 30 (78.5)
  Missing 1 0 .36
 Complications
  No 48 (92.3) 44 (86.3)
  Yes 4 (7.7) 7 (13.7)
   ICU admission 1 (1.9) 3 (5.9)
   Hemorrhage 0 1 (2.0)

Data are n [median (95% confidence interval)] or n (%) unless otherwise specified.

*

Wilcoxon rank-sum test.

Morphine equivalents.

Fisher exact test.

§

Chi-squared test.

ICU, intensive care unit.